High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families

被引:30
作者
Katagiri, T
Kasumi, F
Yoshimoto, M
Nomizu, T
Asaishi, K
Abe, R
Tsuchiya, A
Sugano, M
Takai, S
Yoneda, M
Fukutomi, T
Nanba, K
Makita, M
Okazaki, H
Hirata, K
Okazaki, M
Furutsuma, Y
Morishita, Y
Iino, Y
Karino, T
Ayabe, H
Hara, S
Kajiwara, T
Houga, S
Shimizu, T
Toda, M
Yamazaki, Y
Uchida, T
Kunitomo, K
Sonoo, H
Kurebayashi, J
Shimotsuma, K
Nakamura, Y
Miki, Y
机构
[1] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Human Genome Anal, Toshima Ku, Tokyo 170, Japan
[2] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo, Japan
[3] Japanese Fdn Canc Res, Dept Surg, Tokyo 170, Japan
[4] Hoshi Gen Hosp, Dept Surg, Koriyama, Fukushima, Japan
[5] Sapporo Kotoni Nyuusen Clin, Sapporo, Hokkaido, Japan
[6] Fukushima Med Coll, Dept Surg 2, Fukushima, Japan
[7] Osaka Univ, Sch Med, Dept Surg Oncol, Osaka, Japan
[8] Natl Canc Ctr, Dept Surg, Tokyo, Japan
[9] Breastpia Namba Hosp, Dept Surg, Miyazaki, Japan
[10] Shin Sapporo Nyuusen Clin, Sapporo, Hokkaido, Japan
[11] Sapporo Med Coll, Dept Surg 1, Sapporo, Hokkaido 060, Japan
[12] Furutsuma Clin, Osaka, Japan
[13] Gunma Univ, Sch Med, Dept Surg 2, Maebashi, Gumma 371, Japan
[14] Nagasaki Univ, Sch Med, Dept Surg 1, Nagasaki 852, Japan
[15] Tokyo Womens Med Coll, Daini Hosp, Dept Surg, Tokyo 162, Japan
[16] Tokyo Metropolitan Komagome Hosp, Tokyo, Japan
[17] Jikeikai Univ, Sch Med, Dept Surg 1, Tokyo, Japan
[18] Tezuka Hosp, Tokushima, Japan
[19] Kawasaki Med Sch, Dept Endocrine Surg, Kurashiki, Okayama, Japan
关键词
BRCA1; BRCA2; breast cancer family; germline mutation; missense mutation;
D O I
10.1007/s100380050035
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mutations in either of two recently identified genes, BRCA1 and BRCA2, are thought to be responsible for approximately two-thirds of all cases of autosomal-dominantly inherited breast cancer. To examine the nature and frequency of BRCA1 and BRCA2 mutations in Japanese families exhibiting a high incidence of breast cancer, we screened 78 unrelated families in this category for mutations of these two genes. Examining the entire coding sequences as well as exon-intron boundaries of both genes by polymerase chain reaction (PCR) single-strand conformation polymorphism (SSCP) and multiplex-SSCP analysis, we identified possible disease-causing alterations in BRCA1 among affected members of 15 families and in BRCA2 in another 14 families. In 15 of those 29 families, the affected individuals carried missense mutations, although most germline mutations reported worldwide have been deletions or nonsense mutations. Our results, indicating that missense mutations of BRCA1 and BRCA2 tend to predominate over frameshifts or nonsense mutations in Japanese breast cancer families, will contribute significantly to an understanding of mammary tumorigenesis in Japan, and will be of vital importance for future genetic testing.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1994, CANC FACTS FIG
[2]  
Berman DB, 1996, AM J HUM GENET, V58, P1166
[3]   BRCA2 germline mutations in male breast cancer cases and breast cancer families [J].
Couch, FJ ;
Farid, LM ;
DeShano, ML ;
Tavtigian, SV ;
Calzone, K ;
Campeau, L ;
Peng, Y ;
Bogden, B ;
Chen, Q ;
Neuhausen, S ;
ShattuckEidens, D ;
Godwin, AK ;
Daly, M ;
Radford, DM ;
Sedlacek, S ;
Rommens, J ;
Simard, J ;
Garber, J ;
Merajver, S ;
Weber, BL .
NATURE GENETICS, 1996, 13 (01) :123-125
[4]  
de Waard F, 1981, Nutr Cancer, V2, P237
[5]   Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer [J].
FitzGerald, MG ;
MacDonald, DJ ;
Krainer, M ;
Hoover, I ;
ONeil, E ;
Unsal, H ;
SilvaArrieto, S ;
Finkelstein, DM ;
BeerRomero, P ;
Englert, C ;
Sgroi, DC ;
Smith, BL ;
Younger, JW ;
Garber, JE ;
Duda, RB ;
Mayzel, KA ;
Isselbacher, KJ ;
Friend, SH ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :143-149
[6]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[7]  
Goggins M, 1996, CANCER RES, V56, P5360
[8]  
INOUE R, 1995, CANCER RES, V55, P3521
[9]  
Johannesdottir G, 1996, CANCER RES, V56, P3663
[10]  
Katagiri T, 1996, CANCER RES, V56, P4575